ISSUES RAISED BY HUMAN CLONING RESEARCH HEARING ...

C O N T E N T SPageTestimony of:Boisselier, Brigitte, Scientific Director, Clonaid ............................................ 52Cameron, Nigel M. de S., Principal, Strategic Futures Group ..................... 103Caplan, Arthur L., Director, Center of Bioethics, University of Pennsylvania.............................................................................................................. 95Eibert, Mark D., the Law Offices of Mark Eibert .......................................... 107Hanson, Jayde, Assistant General Secretary, General Board of Churchand Society, the United Methodist Church ................................................ 129Jaenisch, Rudolph, Professor of Biology, Massachusetts Institute of Technology............................................................................................................. 44Murray, Thomas H., National Bioethics Advisory Commission ................... 81Okarma, Thomas B., President and CEO, Geron Corporation ..................... 34Pence, Gregory, Professor of Philosophy, School of Medicine and Humanities,University of Alabama at Birmingham ............................................. 100Rael, Leader, Raelian Movement .................................................................... 132Soules, Michael R., President, American Society of Reproductive Medicine................................................................................................................. 120Terry, Sharon F., Genetics Alliance, Inc ........................................................ 118Westhusin, Mark E., Associate Professor, Texas A&M University, Collegeof Veterinary Medicine ................................................................................. 38Wicker, Randolfe H., Founder, Clone Rights United Front, spokesmanfor the Human Cloning Foundation ............................................................ 124Zavos, Panos Michael, Founder, Director and Chief Andrologist,Andrology Institute of America .................................................................... 47Zoon, Kathryn C., Director, Center for Biologics Evaluation and Research,Food and Drug Administration .................................................................... 78Material submitted for the record by:Best, Robert A., President, Culture of Life Institute, prepared statementof ..................................................................................................................... 145Mitchell, C. Ben, prepared statement of ......................................................... 148(III)3VerDate 11-MAY-2000 07:46 May 24, 2001 Jkt 000000 PO 00000 Frm 00003 Fmt 0486 Sfmt 0486 71495.TXT HCOM2 PsN: HCOM2